Reshape Lifesciences Stock News

The stock price of ReShape Lifesciences Inc (NASDAQ: RSLS) increased by over 19% pre-market today. This is why it happened.

SAN CLEMENTE, Calif., Dec. 9, 2021 /PRNewswire/ -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that Bart

State Street Corp purchased a new position in ReShape Lifesciences Inc. (OTCMKTS:RSLS) in the second quarter, HoldingsChannel reports. The fund purchased 109,999 shares of the medical device companys stock, valued at approximately $550,000. Other hedge funds also recently added to or reduced their stakes in the company. Alpine Global Management LLC bought a new position []

ReShape Lifesciences Inc. (NASDAQ:RSLS) concluded the trading at $1.69 on Friday, December 03 with a fall of -5.06% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $1.78 and 5Y monthly beta was reading 1.70 with its price kept floating in the Analysts Release Price Targets And Ratings For ReShape Lifesciences Inc. (RSLS) Read More »

Himax Technologies, Inc. (HIMX) with the stream of 0.81% also noticed, India ReShape Lifesciences Inc. (RSLS) encountered a rapid change of -1.98% in the last hour of Mondays trading session. The post Traders cant mares this Stock: Himax Technologies, Inc. (NASDAQ:HIMX), ReShape Lifesciences Inc. (NASDAQ:RSLS) appeared first on Stocks Equity .

Vanguard Group Inc. purchased a new position in ReShape Lifesciences Inc. (OTCMKTS:RSLS) during the second quarter, Holdings Channel reports. The fund purchased 51,120 shares of the medical device companys stock, valued at approximately $256,000. A number of equities research analysts recently issued reports on the company. Alliance Global Partners restated a buy rating and issued []

ReShape Lifesciences Inc. (NASDAQ:RSLS) price on Friday, November 19, fall -0.99% below its previous days close as a downside momentum from buyers pushed the stocks value to $2.01. A look at the stocks price movement, the close in the last trading session was $2.03, moving within a range at $1.95 and $2.05. The beta value ReShape Lifesciences Inc. (RSLS): An Important Analyst Insights Read More »

ReShape Lifesciences Inc. (OTCMKTS:RSLS) CFO Thomas Stankovich sold 4,320 shares of the companys stock in a transaction dated Tuesday, November 2nd. The stock was sold at an average price of $2.69, for a total value of $11,620.80. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Thomas []

National advertising campaign and Virtual Media Tour achieve all key performance indicators SAN CLEMENTE, Calif., Nov. 16, 2021 (GLOBE NEWSWIRE) ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss and metabolic health-solutions company, previously announced successful campaigns to help more consumers take control of their lives and their weight with a national direct-to-consumer television The post ReShape Lifesciences Witnesses Great Success with Direct-to-Consumer Marketing Campaign appeared first on ForexTV .

In the latest trading session, 1.09 million ReShape Lifesciences Inc. (NASDAQ:RSLS) shares changed hands as the companys beta touched -1.16. With the companys most recent per share price at $2.18 changed hands at -$0.19 or -8.02% at last look, the market valuation stands at $39.39M. RSLSs current price is a discount, trading about -1382.11% off The Stock Of ReShape Lifesciences Inc. (NASDAQ: RSLS) Was Forecast By Analysts To Close At $10.25 Per Share By 2021. Read More »

Maxim Group reissued their buy rating on shares of ReShape Lifesciences (OTCMKTS:RSLS) in a research note issued to investors on Friday morning, TipRanks reports. They currently have a $8.00 price objective on the medical device companys stock. Separately, Alliance Global Partners reiterated a buy rating and issued a $10.25 target price (down from $13.75) on []

ReShape Lifesciences Inc. (RSLS) CEO Bart Bandy on Q3 2021 Results - Earnings Call Transcript

SAN CLEMENTE, Calif., Nov. 08, 2021 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss and metabolic health-solutions company, announced today that it w

SAN CLEMENTE, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss and metabolic health-solutions company, announced Thomas Stankovi

Are these penny stocks worth watching right now? The post Popular Penny Stocks to Buy in October?